Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa
Yusuke Shimakawa(Institut Pasteur), Maud Lemoine(St Mary's Hospital), Ignatius Baldeh(Ministry of Health and Social Welfare), Mark Thursz(St Mary's Hospital), Kazushige Moriyama(Fujirebio (Japan)), Katsumi Aoyagi(Fujirebio (Japan)), Shevanthi Nayagam(Imperial College Healthcare NHS Trust), Umberto D’Alessandro(MRC Unit the Gambia), Isabelle Chemin(Inserm), Shunji Mishiro(Tokyo Shinagawa Hospital), Adam Jeng(MRC Unit the Gambia), Sheikh Mohammad Fazle Akbar(Ehime University), Amie Ceesay(MRC Unit the Gambia), Masayasu Imaizumi(Fujirebio (Japan)), Harr Freeya Njai(MRC Unit the Gambia), Bakary Sanneh(Ministry of Health and Social Welfare), Gibril Ndow(MRC Unit the Gambia), Maimuna Mendy(Centre international de recherche sur le cancer), Damien Cohen(Université Claude Bernard Lyon 1), Ramou Njie(MRC Unit the Gambia), Kazuaki Takahashi(Tokyo Shinagawa Hospital)
Cited by 42
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439